Autopsy report · NCT05709535
PSMA-PET/CT Registry
Cause of deathFunding or business
“Not due to a safety concern; terminated early due to changing clinical trial landscape at centre”
Life of this trial
- Registered 6 months before it started.
- Ran for about 1 year 4 months before it stopped.
- 128 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Sponsor
- AHS Cancer Control Alberta
- Sponsor type
- University, hospital or other
- Conditions
- Prostate Cancer
- Interventions
- [18F]-PSMA-1007
- Participants
- 128
- Sites
- 1
- Countries
- Canada
Trials that died the same way
- A Phase 1b Proof-of-concept Trial Exploring the Effects of FE 999322 and FE 999324 in Adults With Mild to Moderate Ulcerative Colitis
“Not due to safety concerns, but changes in strategy which this trial no longer fulfills.” - Stent-Retriever for Acute Massive Pulmonary Embolism (SRAME)
“The clinical trial was terminated ahead of schedule due to strategic changes within the company.” - Exploratory Study of Farletuzumab to Treat Resectable, Non-functioning Pituitary Adenomas
“Trial terminated due to focus of primary therapeutic areas.” - Neoadjuvant Lu-PSMA Radioligand Therapy and Ipilimumab in Men With Very High-risk Prostate Cancer
“The clinical trial has been terminated due to the revocation of funding. Although one subject was enrolled, the participant withdrew prior to receiving any treatment. No trial-related procedures generating evaluable clinical data were performed.” - Study of Inlexisertib (DCC-3116) in Participants With RAS/MAPK Pathway Mutant Solid Tumors
“Trial terminated due to business decision, not based on any safety or efficacy concerns.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.